バイオマーカー探索アウトソーシングサービスの世界市場レポート 2025年

バイオマーカー探索アウトソーシングサービス市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR16.4％で312億2,000万米ドルに成長します。予測期間の成長は、個別化医療の拡大、AIと機械学習の統合、プレシジョン・オンコロジーの成長、バイオマーカー検証サービス、規制支援、標的治療の需要、患者中心のヘルスケアに起因すると考えられます。予測期間における世界の動向には、精密医療の採用拡大、技術の進歩、コンパニオン診断の需要増加、医薬品開発パイプラインの拡大、非伝統的疾患領域における新たな応用、人工知能（AI）と機械学習（ML）の統合、規制支援と標準化、世界市場の拡大、パートナーシップと提携、費用対効果と時間効率の重視などが含まれます。

個別化医療が重視されるようになったことで、バイオマーカー探索アウトソーシングサービス市場の成長が促進されようとしています。個別化医療は、正確なヘルスケア結果と副作用の低減のために、遺伝的要因、ライフスタイル要因、環境要因を考慮しながら、患者一人ひとりの特性に合わせた治療を行うものです。バイオマーカー探索サービスのアウトソーシングは、患者固有の生物学的マーカーに基づいてカスタマイズされた診断・治療ソリューションを提供することで、個別化医療の進展をサポートします。例えば、個別化医療連合（Personalized Medicine Coalition）の報告によると、FDAは2024年2月、希少疾患患者向けに16の新たな個別化治療を承認し、2022年の6件から増加しました。このような個別化治療の急増は、個別化医療への注目の高まりを浮き彫りにし、バイオマーカー探索アウトソーシングサービスの需要に拍車をかけています。

バイオマーカー探索アウトソーシングサービス市場の主要企業は、患者の予後を改善し、バイオマーカー探索の進歩を促進するために、免疫プロテオミクス探索プラットフォームのような多重化バイオマーカーアッセイの開発に注力しています。免疫プロテオミクス探索プラットフォームは、免疫学とプロテオミクスを組み合わせ、免疫反応に関連するタンパク質を同定・解析します。例えば、Sengenics Corporation LLCは2023年10月にイムノプロテオミクス・ディスカバリー・プラットフォームを立ち上げ、疾患関連自己抗体を分析するための包括的なタンパク質マイクロアレイ・プラットフォームを提供しています。このプラットフォームは免疫バイオマーカー探索を支援し、学界や臨床バイオ製薬部門の研究チームがタンパク質相互作用や疾患動態をよりよく理解できるようサポートします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バイオマーカー探索アウトソーシングサービス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバイオマーカー探索アウトソーシングサービス市場：成長率分析
• 世界のバイオマーカー探索アウトソーシングサービス市場の実績：規模と成長, 2019-2024
• 世界のバイオマーカー探索アウトソーシングサービス市場の予測：規模と成長, 2024-2029, 2034F
• 世界バイオマーカー探索アウトソーシングサービス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオマーカー探索アウトソーシングサービス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 予測バイオマーカー
• 予後バイオマーカー
• 安全性バイオマーカー
• 代替エンドポイント
• 世界のバイオマーカー探索アウトソーシングサービス市場発見フェーズ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオマーカーの同定
• バイオマーカー検証
• バイオマーカープロファイリング
• バイオマーカーパネル開発
• バイオマーカーの選択
• 世界のバイオマーカー探索アウトソーシングサービス市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 心臓病学
• 神経学
• 自己免疫疾患
• その他の治療領域
• 世界のバイオマーカー探索アウトソーシングサービス市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• バイオテクノロジー企業
• 世界のバイオマーカー探索アウトソーシングサービス市場予測バイオマーカーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疾病リスク評価
• 治療反応予測
• 個別化医療ガイダンス
• 世界のバイオマーカー探索アウトソーシングサービス市場予後バイオマーカーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病気の進行予測
• 患者の生存予測
• 再発リスク評価
• 世界のバイオマーカー探索アウトソーシングサービス市場安全性バイオマーカーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 毒性予測
• 医薬品安全性評価
• 有害影響リスク評価
• 世界のバイオマーカー探索アウトソーシングサービス市場代替エンドポイントのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床試験結果指標
• 病気の進行モニタリング
• 治療効果の追跡

第7章 地域別・国別分析

• 世界のバイオマーカー探索アウトソーシングサービス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオマーカー探索アウトソーシングサービス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオマーカー探索アウトソーシングサービス市場：競合情勢
• バイオマーカー探索アウトソーシングサービス市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Labcorp Drug Development Inc. Overview, Products and Services, Strategy and Financial Analysis
  • ICON plc Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • WuXi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Syneos Health Inc.
• Intertek Group plc
• Charles River Laboratories International Inc.
• Parexel International Corporation
• QIAGEN N.V.
• Medpace Inc.
• Bioclinica Inc.
• Evotec SE
• GenScript Biotech Corporation
• Precision for Medicine Inc.
• BioAgilytix Labs LLC
• Celerion Inc.
• Frontage Laboratories Inc.
• SomaLogic Inc.
• Selvita S.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオマーカー探索アウトソーシングサービス市場2029：新たな機会を提供する国
• バイオマーカー探索アウトソーシングサービス市場2029：新たな機会を提供するセグメント
• バイオマーカー探索アウトソーシングサービス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Biomarker discovery outsourcing services refer to specialized services provided by external organizations or companies that assist in identifying, validating, and developing biomarkers. These services play a crucial role in advancing personalized medicine by enabling the identification of biological markers that can guide diagnosis, prognosis, and therapeutic decisions tailored to individual patients.

The main types of biomarker discovery outsourcing services include predictive biomarkers, prognostic biomarkers, safety biomarkers, and surrogate endpoints. Predictive biomarkers are biological indicators used to identify which patients are likely to benefit from a specific therapeutic intervention. The discovery phases encompass biomarker identification, validation, profiling, panel development, and selection, catering to therapeutic areas such as oncology, cardiology, neurology, autoimmune diseases, and others. End users of these services primarily include pharmaceutical and biotechnology companies.

The biomarker discovery outsourcing services market research report is one of a series of new reports from The Business Research Company that provides biomarker discovery outsourcing services market statistics, including biomarker discovery outsourcing services industry global market size, regional shares, competitors with an biomarker discovery outsourcing services market share, detailed biomarker discovery outsourcing services market segments, market trends and opportunities, and any further data you may need to thrive in the biomarker discovery outsourcing services industry. This biomarker discovery outsourcing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomarker discovery outsourcing services market size has grown rapidly in recent years. It will grow from $14.58 billion in 2024 to $17.01 billion in 2025 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to increasing disease burden, pharmaceutical R&D demand, the regulatory environment, cost-effective solutions, research collaboration, and globalization.

The biomarker discovery outsourcing services market size is expected to see rapid growth in the next few years. It will grow to $31.22 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to personalized medicine expansion, AI and machine learning integration, precision oncology growth, biomarker validation services, regulatory support, targeted therapy demand, and patient-centric healthcare. Major trends in the forecast period include increased adoption of precision medicine, technological advancements, rising demand for companion diagnostics, expansion of drug development pipelines, emerging applications in non-traditional disease areas, integration of artificial intelligence (AI) and machine learning (ML), regulatory support and standardization, global market expansion, partnerships and collaborations, and a and a focus on cost-effectiveness and time efficiency.

The increasing emphasis on personalized medicine is set to drive the growth of the biomarker discovery outsourcing services market. Personalized medicine tailors medical treatment to each patient's individual characteristics, considering genetic, lifestyle, and environmental factors for precise healthcare outcomes and reduced adverse effects. Outsourcing biomarker discovery services supports the advancement of personalized medicine by offering customized diagnostic and therapeutic solutions based on patients' unique biological markers. For example, in February 2024, the FDA approved 16 new personalized treatments for rare disease patients, marking an increase from six approvals in 2022, as reported by the Personalized Medicine Coalition. This surge in personalized treatments highlights the growing focus on personalized medicine, fueling the demand for biomarker discovery outsourcing services.

Leading companies in the biomarker discovery outsourcing services market are concentrating on developing multiplexed biomarker assays, such as the immunoproteomic discovery platform, to enhance patient outcomes and drive advancements in biomarker discovery. The immunoproteomic discovery platform combines immunology and proteomics to identify and analyze proteins linked to the immune response. For instance, Sengenics Corporation LLC launched the immunoproteomic discovery platform in October 2023, offering a comprehensive protein microarray platform for analyzing disease-associated autoantibodies. This platform aids in immune biomarker discovery, supporting research teams in academia and clinical biopharmaceutical sectors to better understand protein interactions and disease dynamics.

In August 2022, Fujirebio Holdings Inc., a Japan-based company specializing in diagnostics, acquired ADx NeuroSciences for $44 million. This acquisition enables Fujirebio to expand its portfolio of in vitro diagnostics and enhance its expertise in biomarker development, with the goal of accelerating innovations in neurological testing. ADx NeuroSciences is a Belgium-based company that specializes in biomarker discovery assays and outsourcing services.

Major companies operating in the biomarker discovery outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC, Crown Bioscience Inc.

North America was the largest region in the biomarker discovery outsourcing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker discovery outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biomarker discovery outsourcing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biomarker discovery outsourcing services market includes revenues earned by entities through validation and verification studies, clinical sample analysis, bioinformatics, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomarker Discovery Outsourcing Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomarker discovery outsourcing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biomarker discovery outsourcing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biomarker discovery outsourcing services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Predictive Biomarkers; Prognostic Biomarkers; Safety Biomarkers; Surrogate Endpoints
• 2) By Discovery Phase: Biomarker Identification; Biomarker Validation; Biomarker Profiling; Biomarker Panel Development; Biomarker Selection
• 3) By Therapeutic Area: Oncology; Cardiology; Neurology; Autoimmune Diseases; Other Therapeutic Areas
• 4) By End Use: Pharmaceutical Companies; Biotechnology Companies
• Subsegments:
• 1) By Predictive Biomarkers: Disease Risk Assessment; Therapy Response Prediction; Personalized Medicine Guidance
• 2) By Prognostic Biomarkers: Disease Progression Prediction; Patient Survival Forecast; Recurrence Risk Assessment
• 3) By Safety Biomarkers: Toxicity Prediction; Drug Safety Evaluation; Adverse Effect Risk Assessment
• 4) By Surrogate Endpoints: Clinical Trial Outcome Indicators; Disease Progression Monitoring; Therapy Efficacy Tracking
• Companies Mentioned: Thermo Fisher Scientific Inc.; Labcorp Drug Development Inc.; ICON plc; Eurofins Scientific SE; WuXi AppTec Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biomarker Discovery Outsourcing Services Market Characteristics

3. Biomarker Discovery Outsourcing Services Market Trends And Strategies

4. Biomarker Discovery Outsourcing Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biomarker Discovery Outsourcing Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biomarker Discovery Outsourcing Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biomarker Discovery Outsourcing Services Market Growth Rate Analysis
• 5.4. Global Biomarker Discovery Outsourcing Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biomarker Discovery Outsourcing Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biomarker Discovery Outsourcing Services Total Addressable Market (TAM)

6. Biomarker Discovery Outsourcing Services Market Segmentation

• 6.1. Global Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Biomarkers
• Prognostic Biomarkers
• Safety Biomarkers
• Surrogate Endpoints
• 6.2. Global Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biomarker Identification
• Biomarker Validation
• Biomarker Profiling
• Biomarker Panel Development
• Biomarker Selection
• 6.3. Global Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiology
• Neurology
• Autoimmune Diseases
• Other Therapeutic Areas
• 6.4. Global Biomarker Discovery Outsourcing Services Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Companies
• 6.5. Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease Risk Assessment
• Therapy Response Prediction
• Personalized Medicine Guidance
• 6.6. Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease Progression Prediction
• Patient Survival Forecast
• Recurrence Risk Assessment
• 6.7. Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Safety Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Toxicity Prediction
• Drug Safety Evaluation
• Adverse Effect Risk Assessment
• 6.8. Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Surrogate Endpoints, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Trial Outcome Indicators
• Disease Progression Monitoring
• Therapy Efficacy Tracking

7. Biomarker Discovery Outsourcing Services Market Regional And Country Analysis

• 7.1. Global Biomarker Discovery Outsourcing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biomarker Discovery Outsourcing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biomarker Discovery Outsourcing Services Market

• 8.1. Asia-Pacific Biomarker Discovery Outsourcing Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biomarker Discovery Outsourcing Services Market

• 9.1. China Biomarker Discovery Outsourcing Services Market Overview
• 9.2. China Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biomarker Discovery Outsourcing Services Market

• 10.1. India Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biomarker Discovery Outsourcing Services Market

• 11.1. Japan Biomarker Discovery Outsourcing Services Market Overview
• 11.2. Japan Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biomarker Discovery Outsourcing Services Market

• 12.1. Australia Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biomarker Discovery Outsourcing Services Market

• 13.1. Indonesia Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biomarker Discovery Outsourcing Services Market

• 14.1. South Korea Biomarker Discovery Outsourcing Services Market Overview
• 14.2. South Korea Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biomarker Discovery Outsourcing Services Market

• 15.1. Western Europe Biomarker Discovery Outsourcing Services Market Overview
• 15.2. Western Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biomarker Discovery Outsourcing Services Market

• 16.1. UK Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biomarker Discovery Outsourcing Services Market

• 17.1. Germany Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biomarker Discovery Outsourcing Services Market

• 18.1. France Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biomarker Discovery Outsourcing Services Market

• 19.1. Italy Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biomarker Discovery Outsourcing Services Market

• 20.1. Spain Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biomarker Discovery Outsourcing Services Market

• 21.1. Eastern Europe Biomarker Discovery Outsourcing Services Market Overview
• 21.2. Eastern Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biomarker Discovery Outsourcing Services Market

• 22.1. Russia Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biomarker Discovery Outsourcing Services Market

• 23.1. North America Biomarker Discovery Outsourcing Services Market Overview
• 23.2. North America Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biomarker Discovery Outsourcing Services Market

• 24.1. USA Biomarker Discovery Outsourcing Services Market Overview
• 24.2. USA Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biomarker Discovery Outsourcing Services Market

• 25.1. Canada Biomarker Discovery Outsourcing Services Market Overview
• 25.2. Canada Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biomarker Discovery Outsourcing Services Market

• 26.1. South America Biomarker Discovery Outsourcing Services Market Overview
• 26.2. South America Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biomarker Discovery Outsourcing Services Market

• 27.1. Brazil Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biomarker Discovery Outsourcing Services Market

• 28.1. Middle East Biomarker Discovery Outsourcing Services Market Overview
• 28.2. Middle East Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biomarker Discovery Outsourcing Services Market

• 29.1. Africa Biomarker Discovery Outsourcing Services Market Overview
• 29.2. Africa Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biomarker Discovery Outsourcing Services Market Competitive Landscape And Company Profiles

• 30.1. Biomarker Discovery Outsourcing Services Market Competitive Landscape
• 30.2. Biomarker Discovery Outsourcing Services Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Labcorp Drug Development Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. ICON plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. WuXi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Biomarker Discovery Outsourcing Services Market Other Major And Innovative Companies

• 31.1. Syneos Health Inc.
• 31.2. Intertek Group plc
• 31.3. Charles River Laboratories International Inc.
• 31.4. Parexel International Corporation
• 31.5. QIAGEN N.V.
• 31.6. Medpace Inc.
• 31.7. Bioclinica Inc.
• 31.8. Evotec SE
• 31.9. GenScript Biotech Corporation
• 31.10. Precision for Medicine Inc.
• 31.11. BioAgilytix Labs LLC
• 31.12. Celerion Inc.
• 31.13. Frontage Laboratories Inc.
• 31.14. SomaLogic Inc.
• 31.15. Selvita S.A.

32. Global Biomarker Discovery Outsourcing Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biomarker Discovery Outsourcing Services Market

34. Recent Developments In The Biomarker Discovery Outsourcing Services Market

35. Biomarker Discovery Outsourcing Services Market High Potential Countries, Segments and Strategies

• 35.1 Biomarker Discovery Outsourcing Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biomarker Discovery Outsourcing Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biomarker Discovery Outsourcing Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer